FTSJ2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.266000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.526200E-01
Normal-vs-Stage2
6.035600E-01
Normal-vs-Stage3
3.028600E-01
Normal-vs-Stage4
9.652200E-01
Stage1-vs-Stage2
7.281600E-01
Stage1-vs-Stage3
1.943430E-01
Stage1-vs-Stage4
6.484400E-01
Stage2-vs-Stage3
2.735800E-01
Stage2-vs-Stage4
5.125000E-01
Stage3-vs-Stage4
1.970000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.096400E-01
Normal-vs-AfricanAmerican
9.951800E-01
Normal-vs-Asian
6.365600E-01
Caucasian-vs-AfricanAmerican
4.821000E-01
Caucasian-vs-Asian
8.899600E-01
AfricanAmerican-vs-Asian
5.493200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.722200E-01
Normal-vs-Female
8.439200E-01
Male-vs-Female
9.834100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.757400E-01
Normal-vs-Age(41-60Yrs)
9.673800E-01
Normal-vs-Age(61-80Yrs)
3.934200E-01
Normal-vs-Age(81-100Yrs)
6.208000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.413800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.662400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.740000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.441700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.195400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.696200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.021200E-01
Normal-vs-Daily Drinker
4.640600E-01
Normal-vs-Weekly Drinker
9.324800E-01
Normal-vs-Occasional Drinker
8.314400E-01
Normal-vs-Social Drinker
9.743400E-01
Non Drinker-vs-Daily Drinker
1.112010E-01
Non Drinker-vs-Weekly Drinker
2.182000E-01
Non Drinker-vs-Occasional Drinker
4.063600E-03
Non Drinker-vs-Social Drinker
2.338300E-03
Daily Drinker-vs-Weekly Drinker
4.611800E-01
Daily Drinker-vs-Occasional Drinker
2.508800E-01
Daily Drinker-vs-Social Drinker
1.642230E-01
Weekly Drinker-vs-Occasional Drinker
7.427400E-01
Weekly Drinker-vs-Social Drinker
8.375000E-01
Occasional Drinker-vs-Social Drinker
7.346400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.751800E-01
Normal-vs-Grade 2
6.604600E-01
Normal-vs-Grade 3
6.747800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.318000E-01
Grade 1-vs-Grade 3
9.889400E-01
Grade 1-vs-Grade 4
6.751800E-01
Grade 2-vs-Grade 3
1.790850E-01
Grade 2-vs-Grade 4
6.604600E-01
Grade 3-vs-Grade 4
6.747800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.128000E-01
Normal-vs-NonDiabetic
7.661800E-01
Diabetic-vs-NonDiabetic
1.362400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.459800E-01
Normal-vs-NoPancreatitis
6.339400E-01
Pancreatitis-vs-NoPancreatitis
9.452200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.041600E-01
Normal-vs-N1
6.825600E-01
N0-vs-N1
5.957200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.661400E-01
Normal-vs-TP53-NonMutant
7.703800E-01
TP53-Mutant-vs-TP53-NonMutant
1.450050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
